Amber Salter, Ph.D.

Section Head, Statistical Planning & Analysis

Associate Professor

Endowed Title: Kenney Marie Dixon-Pickens Distinguished Professorship in Multiple Sclerosis Research
School: Medical School
Department: Neurology | Peter O'Donnell Jr. Brain Institute

Biography

Dr. Amber Salter is an Associate Professor of Biostatistics at UT Southwestern. She graduated from the University of Alabama at Birmingham with a PhD in Biostatistics in 2015 and has a MPH in Epidemiology. She holds joint appointments in the Department of Population and Data Sciences and the Peter O’Donnell Jr. Brain Institute.

Dr. Salter’s research interest are in the design, analysis and interpretation of clinical trials and epidemiologic studies with a heavy focus in the area of Multiple Sclerosis (MS). She is also interested in the design and analysis of large complex databases and the issues and implications of their use in practice. She has been conducting research in the disease area of MS for over 10 years, specifically working with a disease registry, the North American Research Committee on Multiple Sclerosis (NARCOMS) Registry, which collects self-report data from persons with MS semi-annually.

Publications

Does intracranial pressure vary based on external ventricular drainage? A real-world clinical observation study: Kwon D, Riskey L, Kamal A, Doyle BR, Louthen B, Marshall JL, Ruxmohan SD, Salter A, Olson DW Australian Critical Care 2025 Mar 38
Effects of COVID-19 Infection on Symptom Severity and Disability in Multiple Sclerosis: Salter A, Lancia S, Cutter GR, Fox RJ, Marrie RA Neurology 2025 Jan 104 e210149
Post-acute sequela of COVID-19 infection in individuals with multiple sclerosis: Salter A, Lancia S, Cutter GR, Fox RJ, Marrie RA Multiple Sclerosis Journal 2025
Utility of Progression Independent of Relapse Activity as a Trial Outcome in Relapsing-Remitting Multiple Sclerosis: Strijbis EM, Mostert J, Comtois J, Salter A, Repovic P, Bowen JD, Uitdehaag BM, Cutter GR, Koch MW Neurology 2024 Dec 104
Feasibility of Simon 2-Stage Futility Trials in Early Parkinson Disease: Analysis of the PRECEPT and DATATOP Trial Datasets: Koch MW, Kalia LV, Sarna JR, Wile D, Mestre TA, Schlossmacher MG, Mostert J, Strijbis EM, Uitdehaag B, Salter A, Cutter GR Neurology 2024 Dec 104
Cognitive rehabilitation effects on grey matter volume and Go-NoGo activity in progressive multiple sclerosis: results from the CogEx trial: Author Collaboration tC, Rocca MA, Valsasina P, Romanò F, Tedone N, Amato MP, Brichetto G, Boccia VD, Chataway J, Chiaravalloti ND, Cutter G, Dalgas U, Deluca J, Farrell RA, Feys P, Freeman J, Inglese M, Meza C, Motl RW, Salter A, Sandroff BM, Feinstein A, Filippi M, Michelsen AS, Madsen LE, Jørgensen ML, Diedmann MD, Keytsman C, Vanzeir E, Lenaerts J, Knevels L, D'Hooge M, Weerdt ND, Veldkamp R, Donnee R, Vandecasteele S, Vandael V, Cordani C, Sibilia M, Vizzino C, Riccitelli GC, Preziosa P, Podda J, Pedullà L, Tacchino A, Smith A, Bichler B, Morecraft J, Dibenedetto M, Moore N, Holme C Journal of Neurology, Neurosurgery and psychiatry 2024 Dec 95 1139-1149
There Is Significant Within-Subject Variation in the Time from Light Stimulus to Maximum Pupil Constriction Among Healthy Controls: Kamal A, Kim Y, Salter A, Gunna S, Nairon EB, Olson DW Journal of Clinical Medicine 2024 Dec 13
Comorbidity and Disease Activity in Multiple Sclerosis: Salter A, Lancia S, Kowalec K, Fitzgerald KC, Marrie RA JAMA neurology 2024 Nov 81
Clinical outcome and cost effectiveness of acute ischemic stroke transfers for endovascular reperfusion therapy from geographically distant counties: Stroke transfer outcomes: Ray B, Mathews EP, Hernandez RS, Glaser KR, Washington HH, Salter A, Olson DW, Aiyagari V Journal of Stroke and Cerebrovascular Diseases 2024 Nov 33
Evidence of symptom specificity for depression in multiple sclerosis: A two sample Mendelian randomization study: Hu C, Vasileiou ES, Salter A, Marrie RA, Kowalec K, Fitzgerald KC Multiple Sclerosis and Related Disorders 2024 Nov 91